Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (NY:ASX)

10.04 +0.15 (+1.51%)
Streaming Delayed Price Updated: 11:58 AM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ASE Technology Holding Co., Ltd. American Depositary Shares (each representing

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Hibbett, American Software, Ardelyx And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Element 25 Limited to Present at the Clean Energy Metals Virtual Investor Conference August 24th
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’s
New Patent Covers Over 150 Novel Compounds 
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson’s Disease and Movement Disorders
Presentations Highlight New Data on Diagnostic Accuracy and Novel Biomarkers of Disease Severity in Multiple System Atrophy 
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Elevate Uranium Ltd to Present at the Clean Energy Metals Virtual Investor Conference August 24th
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
ASE Holdings Hosts Annual Supplier Day to Recognize Outstanding Suppliers of 2022
From ASE Technology Holding Co., Ltd.
Via Business Wire
Alterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
7 Cheap Dividend Stocks That Smart Investors Will Snap Up Now
Those looking for passive income won’t have to pay full price with these cheap dividend stocks for smart investors to consider. 
Via InvestorPlace
Overview Of Value Stocks In The Technology Sector
Via Benzinga
Appendix 4C – Q4 FY23 Quarterly Cash Flow Report
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
Via Benzinga
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Pushpay Expands Giving Options, Announces Free Stock Donations with Engiven
Pushpay’s innovation in digital giving continues with new stock giving for churches 
From Pushpay
Via GlobeNewswire
American Rare Earths to Present at the Metals and Mining Virtual Investor Conference July 26th
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Plug Power to Supply Two 5 MW PEM Electrolyzers for Australian Green Hydrogen Projects
Plug electrolyzers will contribute to decarbonization of road transportation and natural gas sectors 
From Plug Power, Inc.
Via GlobeNewswire
11 Information Technology Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Via Benzinga
3 Dividend Stocks That Can Double Your Income in 2023
Dividend investing can be a very powerful tool to use in becoming profitable. These dividend stocks provide growth with a guaranteed income. 
Via InvestorPlace
Pushpay Launches Church Tech Check, a New Assessment Tool to Support Effective Utilization of Technology to Fuel Ministries
Pushpay’s data-backed insights help ministries evaluate their digital tools and maximize their potential to build community and increase engagement 
From Pushpay
Via GlobeNewswire
Alterity Therapeutics to Present in MST Access Rare Diseases, Rich Returns Forum on 22 June 2023
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
3 Cheap Growth Stocks That Are Too Good to Pass Up
These top bargain growth stocks are all priced under $10 a share and offer real upside potential for investors. 
Via InvestorPlace
ASE VIPack™ FOCoS-Bridge integrates multiple ASICs and silicon bridges to accelerate AI innovation
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
Alterity Therapeutics Initiates Second Phase 2 Study in Rare Parkinsonian Disorder
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics CEO David Stamler to Present at the SHARE Series Monday Management Update on Monday, May 22, 2023
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Pushpay Announces Everygift™, Suite of Product Features that Enable Churches to Grow Generosity
Streamlined tools and new partnership with Engiven expands giving options and provides a seamless transaction experience for churchgoers 
From Pushpay
Via GlobeNewswire
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 16th and 17th, 2023
From Virtual Investor Conferences
Via GlobeNewswire
Metals & Mining Hybrid Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Appendix 4C – Q3 FY23 Quarterly Cash Flow Report
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics Enrolls First Patient in Australia in ATH434 Global Phase 2 Clinical Trial in Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.